BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10749988)

  • 41. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2.
    Thau N; Jungnickel J; Knippenberg S; Ratzka A; Dengler R; Petri S; Grothe C
    Neurobiol Dis; 2012 Aug; 47(2):248-57. PubMed ID: 22542539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrathecal Delivery of ssAAV9-DAO Extends Survival in SOD1
    Wang W; Duan W; Wang Y; Wen D; Liu Y; Li Z; Hu H; Cui H; Cui C; Lin H; Li C
    Neurochem Res; 2017 Apr; 42(4):986-996. PubMed ID: 28025800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS.
    Bravo-Hernandez M; Tadokoro T; Navarro MR; Platoshyn O; Kobayashi Y; Marsala S; Miyanohara A; Juhas S; Juhasova J; Skalnikova H; Tomori Z; Vanicky I; Studenovska H; Proks V; Chen P; Govea-Perez N; Ditsworth D; Ciacci JD; Gao S; Zhu W; Ahrens ET; Driscoll SP; Glenn TD; McAlonis-Downes M; Da Cruz S; Pfaff SL; Kaspar BK; Cleveland DW; Marsala M
    Nat Med; 2020 Jan; 26(1):118-130. PubMed ID: 31873312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined intramuscular and intraspinal transplant of bone marrow cells improves neuromuscular function in the SOD1
    Martínez-Muriana A; Pastor D; Mancuso R; Rando A; Osta R; Martínez S; López-Vales R; Navarro X
    Stem Cell Res Ther; 2020 Feb; 11(1):53. PubMed ID: 32033585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
    Pitzer C; Krüger C; Plaas C; Kirsch F; Dittgen T; Müller R; Laage R; Kastner S; Suess S; Spoelgen R; Henriques A; Ehrenreich H; Schäbitz WR; Bach A; Schneider A
    Brain; 2008 Dec; 131(Pt 12):3335-47. PubMed ID: 18835867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuregulin-1 promotes functional improvement by enhancing collateral sprouting in SOD1(G93A) ALS mice and after partial muscle denervation.
    Mancuso R; Martínez-Muriana A; Leiva T; Gregorio D; Ariza L; Morell M; Esteban-Pérez J; García-Redondo A; Calvo AC; Atencia-Cibreiro G; Corfas G; Osta R; Bosch A; Navarro X
    Neurobiol Dis; 2016 Nov; 95():168-78. PubMed ID: 27461051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective effects of intrathecal injection of AAV9-RabGGTB-GFP
    Gao T; Huo J; Xin C; Yang J; Liu Q; Dong H; Li R; Liu Y
    Front Aging Neurosci; 2023; 15():1092607. PubMed ID: 36967828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic administration of scAAV9-IGF1 extends survival in SOD1
    Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
    Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit.
    Henriques A; Pitzer C; Dittgen T; Klugmann M; Dupuis L; Schneider A
    Mol Ther; 2011 Feb; 19(2):284-92. PubMed ID: 21139572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya-Shimada W; Nakamura T; Matsumoto K; Matsuyama S; Nakamura T
    Neurosci Res; 2009 Oct; 65(2):194-200. PubMed ID: 19595710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ApoSOD1 lacking dismutase activity neuroprotects motor neurons exposed to beta-methylamino-L-alanine through the Ca
    Petrozziello T; Secondo A; Tedeschi V; Esposito A; Sisalli M; Scorziello A; Di Renzo G; Annunziato L
    Cell Death Differ; 2017 Mar; 24(3):511-522. PubMed ID: 28085149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic infusion of SOD1
    Ramírez-Jarquín UN; Rojas F; van Zundert B; Tapia R
    J Cell Physiol; 2017 Oct; 232(10):2610-2615. PubMed ID: 28128448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons.
    Castillo K; Nassif M; Valenzuela V; Rojas F; Matus S; Mercado G; Court FA; van Zundert B; Hetz C
    Autophagy; 2013 Sep; 9(9):1308-20. PubMed ID: 23851366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of metal concentrations in the SOD1
    Enge TG; Ecroyd H; Jolley DF; Yerbury JJ; Kalmar B; Dosseto A
    Mol Cell Neurosci; 2018 Apr; 88():319-329. PubMed ID: 29524628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene expression changes in spinal motoneurons of the SOD1(G93A) transgenic model for ALS after treatment with G-CSF.
    Henriques A; Kastner S; Chatzikonstantinou E; Pitzer C; Plaas C; Kirsch F; Wafzig O; Krüger C; Spoelgen R; Gonzalez De Aguilar JL; Gretz N; Schneider A
    Front Cell Neurosci; 2014; 8():464. PubMed ID: 25653590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. "Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.
    Coughlan KS; Mitchem MR; Hogg MC; Prehn JH
    Neurobiol Aging; 2015 Feb; 36(2):1140-50. PubMed ID: 25443289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.